Australian Longitudinal Study on Women's Health
Search Icon Created with Sketch.
Icons / Login Created with Sketch.
Icons / User Created with Sketch.
Search Icon Created with Sketch.

Tracking the impact of drug regulatory actions: consumer health outcomes, risk-benefit issues and policy framework - women's comments on Vioxx and medicine safety

Approved: 2011

Collaborators:

  • Prof Lynne Parkinson
  • Prof Julie Byles
  • Mr Richard Gibson
  • Dr Xenia Dolja-Gore
  • Dr Evan Doran
  • Dr Jane Robertson
  • Dr Paul Kowal
  • Dr Jennifer Stewart Williams
  • Ms Payal Patel

Synopsis

The aim of this study will be to explore the qualitative comments provided by older women on their experience of using the COX-2 and other relevant arthritis medicines and switching to alternate medicines, and medicine safety concerns over time. The research questions are: 1. What do older women say about arthritis medicines use and safety? 2. What do older women say about the withdrawal of vioxx? 3. What are the issues and concerns of older women in relation to arthritis medicines?